1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Hemex AG

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Investment Company

Location

Liestal Switzerland

Alternative Asset Classes

PE

Established

2011

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

-
Founded in 2011, Hemex AG is a Swiss investment and consulting company that supports start-ups in innovative drugs, medical devices and in vitro diagnostics sector. Hemex has offices in Switzerland, Germany, and US.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage: Start-up
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

1 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Co-Founder, Chief Executive Officer & Board Member Liestal, Switzerland PE VC

Showing 1 of 1 known decision makers at Hemex AG

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.